GCM
DXCM icon

Glaxis Capital Management’s DexCom DXCM Stock Holding History

Glaxis Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,500
Closed -$850K – 44
2024
Q2 		$850K Buy
+7,500
New +$948K 1.47% 27
2023
Q2 		– Sell
-2,000
Closed -$232K – 44
2023
Q1 		$232K Buy
+2,000
New +$224K 3.46% 14

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Glaxis Capital Management's DXCM Position: Q3 2024 in Review

Glaxis Capital Management sold out of DexCom (DXCM) in Q3 2024, closing a stake of 7,500 shares — an estimated $850K sold.

Glaxis Capital Management first reported a position in DXCM in Q1 2023 and held it in 2 quarters. The position peaked at $850K in Q2 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Glaxis Capital Management reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Glaxis Capital Management sold 7,500 DexCom shares in Q3 2024, an estimated $850K.
  • Glaxis Capital Management first reported a position in DexCom in Q1 2023 and held it in 2 quarters.
  • Glaxis Capital Management's DexCom position peaked at $850K in Q2 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Glaxis Capital Management's 13F filing for Q3 2024, filed 8 Nov 2024.